Please login to the form below

Not currently logged in
Email:
Password:

Ashley Communications celebrates 20 years of medical communications

Looks forward with new business wins, including AbbVie and Merck & Co accounts

Ashley CommunicationsBuckinghamshire, UK-based Ashley Communications marked two decades of medical communications consulting at the close of 2016, a year that saw the firm strengthen its position with several new business wins.

The consultancy is set to put its expertise in strategic counsel, digital and patient engagement, clinical trial communications and opinion leader development to use for eight new clients this year.

Among this number are big pharma firms Abbvie, Allergan and Merck & Co, as well as UK-based Abbott Diagnostics, opioid addiction specialist Indivior, Tokyo-based Otsuka, detection and informatics specialist Perkin Elmer and Torax Medical, a gastroenterology-focused firm.

Ashley Communications chairman Chrissie Ashley, said: “Our key objective for 2016 was to broaden our client base and to fully utilise the therapeutic experience we have within our agency.

“We are delighted with the results, which put us in a strong position starting 2017.

“We also believe our partnership with Southwood research, which was announced earlier this year, has contributed to our success by providing a truly combined service that really adds value to the services we offer our clients.”

Article by
Rebecca Clifford

11th January 2017

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
JPA Health

JPA Health is an award-winning public relations, marketing and advocacy firm known for sharing our clients’ commitment to making people...

Latest intelligence

Personalised medicine: driving a need for greater diversity in clinical trials
Kate Shaw, Innovative Trials' Founder & CEO, investigates one of the biggest challenges facing clinical research today....
Congresses and conferences
Superstar congresses and conferences will stay centre stage but now share the limelight with virtual and hybrid events
With the pandemic having dimmed the lights on pharma conferences, their virtual and hybrid replacements have grasped the opportunity and are here to stay...
Cervical Cancer Prevention Month
In this first 2022 blog, the Innovative Trials' Equality & Diversity committee will be looking at raising awareness around Cervical Cancer...